Skip to main content
BIOX
NASDAQ Industrial Applications And Services

Bioceres Reports $10M Net Loss, Negative EBITDA Amid Revenue Decline and Ongoing Debt Issues

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Consumer
Sentiment info
Negative
Importance info
9
Price
$0.451
Mkt Cap
$28.516M
52W Low
$0.347
52W High
$5.175
52W Position info
30% above low
Off High info
91% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

BIOX sits 30% above its 52-week low of $0.347.

Summary

Bioceres Crop Solutions reported a significant fiscal third-quarter net loss of $10.0 million and negative Adjusted EBITDA, driven by a 23% revenue decline and ongoing challenges following the Pro Farm Group foreclosure.


Key Events · Earnings and Guidance · BIOX

  • Significant Financial Deterioration

    The company reported a net loss of $10.0 million and negative Adjusted EBITDA of $(0.6) million for the fiscal third quarter, a sharp decline from prior year profits.

  • Revenue Decline

    Total revenues fell 23% year-over-year to $39.4 million, impacted by softer demand in Crop Protection and an ongoing transition in the Seeds segment.

  • Gross Margin Contraction

    Gross profit decreased 30% to $12.7 million, with gross margin falling to 32% due to lower revenues, product mix effects, and inventory obsolescence adjustments.

  • Ongoing Liability Management

    Bioceres continues debt reprofiling efforts and a voluntary bond maturity extension process in Argentina, with $108.3 million in secured notes still classified as short-term debt due to a disputed foreclosure.


Analysis · BIOX · Industrial Applications And Services

The substantial net loss of $10.0 million and negative Adjusted EBITDA of $(0.6) million, coupled with a significant 23% revenue decline, confirm a deepening of the company's severe financial distress. These results exacerbate concerns for a company already operating under a going concern warning and facing a Nasdaq delisting threat. The ongoing liability management efforts and the unresolved legal dispute surrounding the Pro Farm Group foreclosure add significant uncertainty to the company's operational and financial future.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 52.8% of the 195 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.69%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BIOX was trading at $0.45 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $28.5M. The 52-week trading range was $0.35 to $5.18. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BIOX - Latest Insights

BIOX
Nov 11, 2026, 5:51 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $0.2327
Real-time Price: $0.1997 info
Change: -$0.033 (-14%) info
Market Cap: $12.744M info
BIOX
Oct 30, 2026, 5:04 PM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $0.208
Real-time Price: $0.1997 info
Change: -$0.0083 (-4%) info
Market Cap: $12.744M info
BIOX
Sep 21, 2026, 6:09 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.346
Real-time Price: $0.1997 info
Change: -$0.1463 (-42%) info
Market Cap: $12.744M info
BIOX
Sep 15, 2026, 7:04 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.392
Real-time Price: $0.1997 info
Change: -$0.1923 (-49%) info
Market Cap: $12.744M info
BIOX
Sep 14, 2026, 6:43 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $0.4342
Real-time Price: $0.1997 info
Change: -$0.2345 (-54%) info
Market Cap: $12.744M info